Clinical trial Recruiting at 10 sites Interventional Ages 75 and up

High-definition surface electromyography to diagnose and monitor sarcopenia

Official title: Preventing Loss of Autonomy in Older Patients by Improving Diagnosis of Sarcopenia and Monitoring With High-definition Surface Electromyography Technology

Run by Assistance Publique - Hôpitaux de Paris · NCT06963359 · Data updated 2026-11-12

This project will try high-definition surface electromyography (HD-sEMG) to see if it can diagnose and monitor sarcopenia in people aged 75 and older who score ≥4 on the SARC-F screening questionnaire.

More Sarcopenia trials

Quick facts

Study typeInterventional
Ages75 Years and up
SexAll
Enrollment846 (estimated)
SponsorAssistance Publique - Hôpitaux de Paris
Academic / other
Locations11 sites (Issy-les-Moulineaux and 10 other locations)
StatusRecruiting
StartedJuly 9, 2025
Main results expectedMarch 2027
Study endsMarch 2027
Registry record updatedFebruary 13, 2026
Trial IDNCT06963359 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are people aged 75 or older hospitalized in acute geriatric or rehabilitation wards who score ≥4 on the SARC-F and meet the study's inclusion and exclusion criteria.

Probably not a fit

Patients with BMI ≥30, pacemakers, bilateral hip prostheses, severe cognitive impairment or psychiatric disease preventing tests, very short life expectancy, skin allergies that prevent electrode use, or those under state medical aid (AME) are excluded and unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter, descriptive, cross-sectional, parallel-group study plans to enroll 846 patients aged 75 and over hospitalized in acute geriatric or rehabilitation wards who screen positive for sarcopenia (SARC-F ≥4). Investigators will record HD-sEMG signals and extract features to develop diagnostic markers, alongside quadriceps ultrasound, body composition by bioelectrical impedance (and DEXA when available), grip strength, and the IPAQ physical activity questionnaire. Inclusion is planned over 18 months with an additional 3-month follow-up, and the team aims to build an automatic procedure combining functional and morphological muscle data. The study is coordinated by Assistance Publique–Hôpitaux de Paris across multiple AP-HP hospital sites.

Why it matters

Potential benefit: If successful, HD-sEMG could provide a non-invasive, bedside tool to detect and monitor sarcopenia earlier and more routinely than current imaging-based methods.

How similar studies have gone: Conventional surface EMG has been used to study muscle activity, but applying high-definition sEMG specifically for sarcopenia diagnosis and monitoring is relatively novel with limited clinical validation so far.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patient aged 75 years and over
* Score ≥4 on the SARC-F screening questionnaire
* Enrolled in a social security plan (no AME)
* Informed and consenting patient

Exclusion Criteria:

* BMI ≥30 kg/m2
* Severe psychiatric pathology or severe cognitive disorders that do not allow the performance of examinations
* Patients who are dependent for all acts of daily life
* Patients with a very short life expectancy \<3months
* Pace maker
* Recent fracture or trauma of the preventing dynamic measurement of HD-sEMG recording
* Bilateral hip prosthesis
* Skin problem that may interfere with the recording of surface EMG activity
* Skin allergies to plasters
* Allergies to electrode materials (acrylate)
* Patient under legal protection
* Patient on state medical aid (AME : Aide Médicale d'Etat)

Where it's running

  • Hôpital Corentin Celton, APHP
    Issy-les-Moulineaux, France
    Recruiting
  • Hôpital Corentin Celton, APHP
    Issy-les-Moulineaux, France
    Recruiting
  • Hôpital Charles Foix, APHP
    Ivry-sur-Seine, France
    Recruiting
  • Hôpital Charles Foix, APHP
    Ivry-sur-Seine, France
    Recruiting
  • Hôpital Charles Foix, APHP
    Ivry-sur-Seine, France
    Recruiting
  • Hôpital Rothschild, APHP
    Paris, France
    Recruiting
Show 5 more locations
  • Hôpital Rothschild, APHP
    Paris, France
    Recruiting
  • Hôpital Saint-Antoine, APHP
    Paris, France
    Recruiting
  • Hôpital Bichat, APHP
    Paris, France
    Recruiting
  • Hôpital Tenon, APHP
    Paris, France
    Recruiting
  • Unité d'Explorations fonctionnelles du sujet âgé - Hôpital Charles Foix
    Ivry-sur-Seine, France
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.